Mission:
Contributes to transition:
Contributes to SDG(s):
Drystack has developed a circular and demountable dry-stack system for bricks. By replacing cement with a smart click system, Drystack 100% creates circular facades: demountable, reusable, and built in a fraction of the time. And: a dramatic reduction in environmental impact.
Drystack focuses on two relevant societal challenges: reducing CO2 emissions and increasing the possibilities for the reuse of building materials. The dry stacking system also solves the shortage of bricklayers. As a North Holland-based company, Drystack strengthens the innovative power of our region: from Heerhugowaard, the company is building a scalable ecosystem of construction companies, brick manufacturers, and developers. Drystack combines sustainable impact with a strong revenue model. Moreover, it aligns with the growing demand for circular construction solutions and stricter sustainability requirements in the sector. As a result, Drystack operates in a market that is expected to grow strongly in the coming years.
LinXis is developing a technology that allows it to detect and treat fibrosis more specifically. With this, it aims to offer a solution for millions of people worldwide with this serious condition.
Globally, around 40 million people live with severe blindness. Phosphoenix is developing a brain implant (neuroprosthetic system) that can restore functional vision using AI in people who later in life...
Greencovery has a sustainable solution to reuse residual streams from the food industry and convert them into valuable ingredients. In this way, a cost item, waste processing of residual materials, is transformed into an extra...
Phoenix Metals is an innovative company that recovers valuable raw materials from industrial waste streams such as steel slag, thereby playing an innovative role in the battery market.
Root Sustainability develops AI technology that allows retailers to make smart decisions based on product-specific data to concretely reduce the CO2 footprint in their supply chain. Dispersed data is quickly and efficiently...
Methotrexate is currently the most commonly prescribed basic drug for rheumatoid arthritis worldwide. Sixty to eighty per cent of patients receive this drug. The problem, however, is that methotrexate is too...
Subscribe to our newsletter and stay up to date with news, stories, relevant events and more.
